The latest on managing care, value-based care, insurance markets, payers & providers

Statin Spending Up 156 Percent

Spending on statins increased 156 percent between 2000 and 2005, according to “Trends in Statins Utilization and Expenditures for the U.S. Civilian Noninstitutionalized Population, 2000 and 2005,” issued by the Agency for Healthcare Research and Quality.

In 2000, outpatient prescription expenditures for statins amounted to $7.7 billion. That rose to $19.7 billion in 2005. Statins include drugs such as atorvastatin (Lipitor), fluvastatin (Lescol), pravastatin (Pravachol), and simvastatin (Zocor).

Further, the average annual personal expenditure for statins increased about 37 percent ($484 and $661, respectively) during that time period. The number of prescriptions purchased for statins nearly doubled from 2000 to 2005, rising from 89.7 million to 173.7 million. The number of persons purchasing a statin increased 88 percent from 2000 to 2005, rising from 15.8 million to 29.7.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.